Moreover, ActA can form a non-signaling complex with ALK2 and type II receptors, portraying a crucial regulatory mechanism that dampens the aberrant ActA response in FOP [16,43,44]. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.